Inventor
PUIG DURAN CARLOS
ES15 patents
⚠️ This page may combine multiple inventors who share the name “PUIG DURAN CARLOS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALMIRALL SA
11 patentsUS7964615B2Jun 21, 2011
Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor
ALMIRALL SA15 citations90
US9233108B2Jan 12, 2016
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
ALMIRALL SA9 citations82
US9562039B2Feb 7, 2017
Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both β2 adrenergic receptor agonist and M3 muscarinic receptor antagonist activities
ALMIRALL SA10 citations78
US9757383B2Sep 12, 2017
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
ALMIRALL SA2 citations71
US9549934B2Jan 24, 2017
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
ALMIRALL SA2 citations71
US10005771B2Jun 26, 2018
Bicyclic derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
ALMIRALL SA2 citations70
US9643961B2May 9, 2017
Cyclohexylamine derivatives having β2 adrenergic antagonist and M3 muscarinic antagonist activities
ALMIRALL SA2 citations70
US9579316B2Feb 28, 2017
Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both muscarinic receptor antagonist and β2 adrenergic receptor agonist activities
ALMIRALL SA3 citations67
US9518050B2Dec 13, 2016
Cyclohexyl and quinuclidinyl carbamate derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activity
ALMIRALL SA2 citations57
US10300072B2May 28, 2019
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
ALMIRALL SA0 citations51
US10456390B2Oct 29, 2019
Combinations comprising MABA compounds and corticosteroids
ALMIRALL SA0 citations36
PUIG DURAN CARLOS
2 patentsUS8283342B2Oct 9, 2012
Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor
PUIG DURAN CARLOS6 citations77
US8420669B2Apr 16, 2013
Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the BETA2 adrenergic receptor
PUIG DURAN CARLOS4 citations58